Health and Healthcare
1079 Articles
Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage…
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial…
Merck and Walmart were among Wednesday's biggest gainers on the Dow while Intel and Cisco were among the big losers.
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…
The Stifel view is that it is time for investors to take a more defensive posture, but that doesn’t mean…
The February 28 short interest data have been compared with the previous figures, and short interest in most of these…
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…
The Dow dropped in Tuesday trading, led by downturns at Disney, Merck, Nike, and DowDuPont.
Walmart, General Electric, Merck, and Verizon were biggest losers on the DJIA Tuesday.
The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…
Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…
Merck reported mixed fourth-quarter financial results before the markets opened on Friday.
24/7 Wall St. has put together a preview of Exxon, Apple, Pfizer and other the Dow Jones Industrial Average companies…
The January 12 short interest data have been compared with the previous figures, and short interest in most of these…
With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…
Our top personal finance-related articles today. Your wallet will thank you later.